Skip to main content

Market Overview

Pharmaceutical Stocks In Play Following Merck/Cubist Deal


On Monday, Merck & Co., Inc. (NYSE: MRK) announced a definitive agreement with Cubist Pharmaceuticals (NASDAQ: CBST) under which Merck will acquire Cubist for $102 per share in a transaction with a total value of roughly $9.5 billion.

Cubist was up more than 35 percent Monday morning.

Following the announcement, other pharmaceutical stocks are in play Monday:

Cempra Inc (NASDAQ: CEMP) +6.4 percent
CAS Medical Systems Inc (NASDAQ: CASM) +2.2 percent
Dynavax Technologies Corporation (NASDAQ: DVAX) +0.5 percent
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) -0.7 percent
Repros Therapeutics Inc (NASDAQ: RPRX)


Related Articles (MRK)

View Comments and Join the Discussion!

Posted-In: M&A News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at